Among patients with pulmonary arterial hypertension treated with selexipag, the 10-year survival rate was 60%, according to ...

Panelists discuss how the pathophysiology of pulmonary arterial hypertension involves complex mechanisms across multiple ...

Findings from surveys of women with pulmonary arterial hypertension (PAH) include that 20% of health care providers were ...

Pulmonary arterial hypertension (PAH) is a rare but serious and potentially life-threatening condition that worsens over time. If you or a loved one was recently diagnosed with PAH, you might have ...

Six out of 10 people with pulmonary arterial hypertension who were followed for 10 years in an extension study are still ...

The FDA approved Yutrepia inhalation powder for the treatment of pulmonary arterial hypertension and pulmonary hypertension ...

The study was evaluating pipeline candidate esuberaprost in combination with marketed PAH drug Tyvaso as Tysuberprost in patients with PAH, who showed signs of deterioration on Tyvaso or had a ...